Question: Earnings Contingency, In - Process R&D , Bargain Purchase On January 2 , 2 0 1 2 , Fiser, Inc. acquired Vixen Pharmaceuticals for $

Earnings Contingency, In-Process R&D, Bargain Purchase
On January 2,2012, Fiser, Inc. acquired Vixen Pharmaceuticals for $1.3 billion cash, in a merger. Vixen had two promising products for treating common infections under review by the U.S. Food and Drug Administration. The balance sheets of Fiser and Vixen, immediately prior to the acquisition, are below. Fair value information appears for Vixen's reported assets and liabilities.
Fiser, Inc.Vixen Pharmaceuticals(in thousands)Book ValueBook ValueFair ValueCurrent assets$6,000,000$300,000$300,000Property, plant and equipment50,000,0009,000,0005,000,000Patents10,000,000500,0003,500,000Total assets$66,000,000$9,800,000$8,800,000Liabilities$31,000,000$8,400,000$8,400,000Capital stock20,000,0003,550,000Retained earnings15,000,000(2,150,000)Total liabilities and equity$66,000,000$9,800,000
$1 billion of the purchase price was allocated to previously unreported in-process research and development attributed to Vixen's products under development. The purchase price was low due to Vixen's poor performance in previous yearsVixen reported a retained earnings deficit of $2.15 billion as of the date of acquisition. To close the deal, Fiser agreed to pay the former owners of Vixen $2 for every dollar of total revenue above $50 million reported on sales of Vixen's products over the next two years. This payment, if made at all, would occur at December 31,2013. Fiser expects that there is only a 10 percent chance the payment will be made, as follows:
Total expected revenue on Vixen's products, 2012-2013ProbabilityBelow $50 million0.90$60 million0.08$80 million0.02
(a) Calculate the present value of the earnout agreement, using a 5 percent discount rate.
(Round your answer to nearest thousand dollars.)
$Answer 1
(in thousands)
(b) This acquisition is a bargain purchase. Calculate the gain on acquisition reported by Fiser.
$Answer 2
(in thousands)
(c) Prepare the entry Fiser made to record the business combination(in thousands).
General JournalDescriptionDebitCreditCurrent assets
Property, plant and equipment
Patents
In-process R&DGain on acquisitionGoodwillCapital StockMerger expenses
Liabilities
Cash
In-process R&DGain on acquisitionGoodwillCapital StockMerger expenses
(d) Prepare Fiser's post-combination balance sheet (in thousands).
Fiser, Inc.
Balance Sheet
January 3,2012(in thousands)Current assets
Liabilities
Property, plant and equipment
Capital stock
Patents
Retained earnings
In-process research & development
Total assets
Total liabilities and equity

Step by Step Solution

There are 3 Steps involved in it

1 Expert Approved Answer
Step: 1 Unlock blur-text-image
Question Has Been Solved by an Expert!

Get step-by-step solutions from verified subject matter experts

Step: 2 Unlock
Step: 3 Unlock

Students Have Also Explored These Related Accounting Questions!